GO Annotation
| Category | Term ID | Term description |
|---|---|---|
| Process | GO:0001894 | Tissue homeostasis |
| Process | GO:0006082 | Organic acid metabolic process |
| Process | GO:0006084 | acetyl-CoA metabolic process |
| Process | GO:0006139 | Nucleobase-containing compound metabolic process |
| Process | GO:0006163 | Purine nucleotide metabolic process |
| Process | GO:0006164 | Purine nucleotide biosynthetic process |
| Process | GO:0006629 | Lipid metabolic process |
| Process | GO:0006631 | Fatty acid metabolic process |
| Process | GO:0006633 | Fatty acid biosynthetic process |
| Process | GO:0006637 | acyl-CoA metabolic process |
| Process | GO:0006725 | Cellular aromatic compound metabolic process |
| Process | GO:0006753 | Nucleoside phosphate metabolic process |
| Process | GO:0006790 | Sulfur compound metabolic process |
| Process | GO:0006793 | Phosphorus metabolic process |
| Process | GO:0006796 | Phosphate-containing compound metabolic process |
| Process | GO:0006807 | Nitrogen compound metabolic process |
| Process | GO:0008152 | Metabolic process |
| Process | GO:0008610 | Lipid biosynthetic process |
| Process | GO:0009058 | Biosynthetic process |
| Process | GO:0009117 | Nucleotide metabolic process |
| Process | GO:0009150 | Purine ribonucleotide metabolic process |
| Process | GO:0009152 | Purine ribonucleotide biosynthetic process |
| Process | GO:0009165 | Nucleotide biosynthetic process |
| Process | GO:0009259 | Ribonucleotide metabolic process |
| Process | GO:0009260 | Ribonucleotide biosynthetic process |
| Process | GO:0009719 | Response to endogenous stimulus |
| Process | GO:0009725 | Response to hormone |
| Process | GO:0009987 | Cellular process |
| Process | GO:0010033 | Response to organic substance |
| Process | GO:0014070 | Response to organic cyclic compound |
| Process | GO:0016043 | Cellular component organization |
| Process | GO:0016053 | Organic acid biosynthetic process |
| Process | GO:0018130 | Heterocycle biosynthetic process |
| Process | GO:0019438 | Aromatic compound biosynthetic process |
| Process | GO:0019538 | Protein metabolic process |
| Process | GO:0019637 | Organophosphate metabolic process |
| Process | GO:0019693 | Ribose phosphate metabolic process |
| Process | GO:0019752 | Carboxylic acid metabolic process |
| Process | GO:0022607 | Cellular component assembly |
| Process | GO:0032501 | Multicellular organismal process |
| Process | GO:0032787 | Monocarboxylic acid metabolic process |
| Process | GO:0032870 | Cellular response to hormone stimulus |
| Process | GO:0033865 | Nucleoside bisphosphate metabolic process |
| Process | GO:0033866 | Nucleoside bisphosphate biosynthetic process |
| Process | GO:0033875 | Ribonucleoside bisphosphate metabolic process |
| Process | GO:0034030 | Ribonucleoside bisphosphate biosynthetic process |
| Process | GO:0034032 | Purine nucleoside bisphosphate metabolic process |
| Process | GO:0034033 | Purine nucleoside bisphosphate biosynthetic process |
| Process | GO:0034641 | Cellular nitrogen compound metabolic process |
| Process | GO:0034654 | Nucleobase-containing compound biosynthetic process |
| Process | GO:0034694 | Response to prostaglandin |
| Process | GO:0034695 | Response to prostaglandin E |
| Process | GO:0035383 | Thioester metabolic process |
| Process | GO:0035384 | Thioester biosynthetic process |
| Process | GO:0042221 | Response to chemical |
| Process | GO:0042592 | Homeostatic process |
| Process | GO:0043170 | Macromolecule metabolic process |
| Process | GO:0043436 | Oxoacid metabolic process |
| Process | GO:0043603 | Cellular amide metabolic process |
| Process | GO:0043604 | Amide biosynthetic process |
| Process | GO:0043933 | Protein-containing complex organization |
| Process | GO:0044085 | Cellular component biogenesis |
| Process | GO:0044237 | Cellular metabolic process |
| Process | GO:0044238 | Primary metabolic process |
| Process | GO:0044249 | Cellular biosynthetic process |
| Process | GO:0044255 | Cellular lipid metabolic process |
| Process | GO:0044271 | Cellular nitrogen compound biosynthetic process |
| Process | GO:0044272 | Sulfur compound biosynthetic process |
| Process | GO:0044281 | Small molecule metabolic process |
| Process | GO:0044283 | Small molecule biosynthetic process |
| Process | GO:0046390 | Ribose phosphate biosynthetic process |
| Process | GO:0046394 | Carboxylic acid biosynthetic process |
| Process | GO:0046483 | Heterocycle metabolic process |
| Process | GO:0048871 | Multicellular organismal homeostasis |
| Process | GO:0048878 | Chemical homeostasis |
| Process | GO:0050896 | Response to stimulus |
| Process | GO:0051259 | Protein complex oligomerization |
| Process | GO:0051260 | Protein homooligomerization |
| Process | GO:0051262 | Protein tetramerization |
| Process | GO:0051289 | Protein homotetramerization |
| Process | GO:0051716 | Cellular response to stimulus |
| Process | GO:0055086 | Nucleobase-containing small molecule metabolic process |
| Process | GO:0055088 | Lipid homeostasis |
| Process | GO:0060249 | Anatomical structure homeostasis |
| Process | GO:0065003 | Protein-containing complex assembly |
| Process | GO:0065007 | Biological regulation |
| Process | GO:0065008 | Regulation of biological quality |
| Process | GO:0070887 | Cellular response to chemical stimulus |
| Process | GO:0071310 | Cellular response to organic substance |
| Process | GO:0071379 | Cellular response to prostaglandin stimulus |
| Process | GO:0071380 | Cellular response to prostaglandin E stimulus |
| Process | GO:0071495 | Cellular response to endogenous stimulus |
| Process | GO:0071616 | acyl-CoA biosynthetic process |
| Process | GO:0071704 | Organic substance metabolic process |
| Process | GO:0071840 | Cellular component organization or biogenesis |
| Process | GO:0072330 | Monocarboxylic acid biosynthetic process |
| Process | GO:0072521 | Purine-containing compound metabolic process |
| Process | GO:0072522 | Purine-containing compound biosynthetic process |
| Process | GO:0090407 | Organophosphate biosynthetic process |
| Process | GO:0097305 | Response to alcohol |
| Process | GO:0097306 | Cellular response to alcohol |
| Process | GO:1901135 | Carbohydrate derivative metabolic process |
| Process | GO:1901137 | Carbohydrate derivative biosynthetic process |
| Process | GO:1901293 | Nucleoside phosphate biosynthetic process |
| Process | GO:1901360 | Organic cyclic compound metabolic process |
| Process | GO:1901362 | Organic cyclic compound biosynthetic process |
| Process | GO:1901564 | Organonitrogen compound metabolic process |
| Process | GO:1901566 | Organonitrogen compound biosynthetic process |
| Process | GO:1901576 | Organic substance biosynthetic process |
| Process | GO:1901654 | Response to ketone |
| Process | GO:1901655 | Cellular response to ketone |
| Process | GO:1901700 | Response to oxygen-containing compound |
| Process | GO:1901701 | Cellular response to oxygen-containing compound |
| Process | GO:2001293 | malonyl-CoA metabolic process |
| Process | GO:2001295 | malonyl-CoA biosynthetic process |
| Component | GO:0001650 | Fibrillar center |
| Component | GO:0005622 | Intracellular anatomical structure |
| Component | GO:0005634 | Nucleus |
| Component | GO:0005730 | Nucleolus |
| Component | GO:0005737 | Cytoplasm |
| Component | GO:0005739 | Mitochondrion |
| Component | GO:0005829 | Cytosol |
| Component | GO:0005856 | Cytoskeleton |
| Component | GO:0015629 | Actin cytoskeleton |
| Component | GO:0031974 | Membrane-enclosed lumen |
| Component | GO:0031981 | Nuclear lumen |
| Component | GO:0043226 | Organelle |
| Component | GO:0043227 | Membrane-bounded organelle |
| Component | GO:0043228 | Non-membrane-bounded organelle |
| Component | GO:0043229 | Intracellular organelle |
| Component | GO:0043231 | Intracellular membrane-bounded organelle |
| Component | GO:0043232 | Intracellular non-membrane-bounded organelle |
| Component | GO:0043233 | Organelle lumen |
| Component | GO:0070013 | Intracellular organelle lumen |
| Component | GO:0110165 | Cellular anatomical entity |
| Function | GO:0000166 | Nucleotide binding |
| Function | GO:0003824 | Catalytic activity |
| Function | GO:0003989 | acetyl-CoA carboxylase activity |
| Function | GO:0005488 | Binding |
| Function | GO:0005515 | Protein binding |
| Function | GO:0005524 | ATP binding |
| Function | GO:0009374 | Biotin binding |
| Function | GO:0016421 | CoA carboxylase activity |
| Function | GO:0016874 | Ligase activity |
| Function | GO:0016885 | Ligase activity, forming carbon-carbon bonds |
| Function | GO:0017076 | Purine nucleotide binding |
| Function | GO:0019842 | Vitamin binding |
| Function | GO:0019899 | Enzyme binding |
| Function | GO:0019900 | Kinase binding |
| Function | GO:0030554 | Adenyl nucleotide binding |
| Function | GO:0031406 | Carboxylic acid binding |
| Function | GO:0032553 | Ribonucleotide binding |
| Function | GO:0032555 | Purine ribonucleotide binding |
| Function | GO:0032559 | Adenyl ribonucleotide binding |
| Function | GO:0033218 | Amide binding |
| Function | GO:0033293 | Monocarboxylic acid binding |
| Function | GO:0035639 | Purine ribonucleoside triphosphate binding |
| Function | GO:0036094 | Small molecule binding |
| Function | GO:0042802 | Identical protein binding |
| Function | GO:0043167 | Ion binding |
| Function | GO:0043168 | Anion binding |
| Function | GO:0043169 | Cation binding |
| Function | GO:0043177 | Organic acid binding |
| Function | GO:0046872 | Metal ion binding |
| Function | GO:0097159 | Organic cyclic compound binding |
| Function | GO:0097367 | Carbohydrate derivative binding |
| Function | GO:1901265 | Nucleoside phosphate binding |
| Function | GO:1901363 | Heterocyclic compound binding |
| Function | GO:1901681 | Sulfur compound binding |
Pathway annotation
Expression profile of Acaca in omics data
| ID | GSE109165 |
| Title | Suppression of RGSz1 function optimizes the actions of opioid analgesics by mechanisms that involve the Wnt/β-catenin pathway |
| Organism | Mus musculus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM2934457 | WT_Naive_1 | tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: wildtype treatment: naïve | 5014.0 |
| GSM2934458 | WT_Naive_2 | tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: wildtype treatment: naïve | 9026.0 |
| GSM2934459 | WT_Naive_3 | tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: wildtype treatment: naïve | 9473.0 |
| GSM2934460 | WT_Naive_4 | tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: wildtype treatment: naïve | 7355.0 |
| GSM2934461 | KO_Naive_1 | tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: RGSz1 KO treatment: naïve | 10366.0 |
| GSM2934462 | KO_Naive_2 | tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: RGSz1 KO treatment: naïve | 7703.0 |
| GSM2934463 | KO_Naive_3 | tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: RGSz1 KO treatment: naïve | 5384.0 |
| GSM2934464 | KO_Naive_4 | tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: RGSz1 KO treatment: naïve | 8448.0 |
| GSM2934465 | WT_Morphine_1 | tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: wildtype treatment: morphine | 6113.0 |
| GSM2934466 | WT_Morphine_2 | tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: wildtype treatment: morphine | 5444.0 |
| GSM2934467 | WT_Morphine_3 | tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: wildtype treatment: morphine | 10648.0 |
| GSM2934468 | WT_Morphine_4 | tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: wildtype treatment: morphine | 6718.0 |
| GSM2934469 | KO_Morphine_1 | tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: RGSz1 KO treatment: morphine | 6495.0 |
| GSM2934470 | KO_Morphine_2 | tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: RGSz1 KO treatment: morphine | 3806.0 |
| GSM2934471 | KO_Morphine_3 | tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: RGSz1 KO treatment: morphine | 3846.0 |
| GSM2934472 | KO_Morphine_4 | tissue: brain brain region: Periaqueductal gray region Sex: Male genotype: RGSz1 KO treatment: morphine | 7514.0 |
| ID | GSE125076 |
| Title | A mouse model of acute post-surgical pain |
| Organism | Mus musculus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM3562188 | DRG_WT_sham_1 | strain: C57BL/6 gender: male age: 8 weeks treatment: naïve | 3239.0 |
| GSM3562189 | DRG_WT_sham_2 | strain: C57BL/6 gender: male age: 8 weeks treatment: naïve | 1747.0 |
| GSM3562190 | DRG_WT_sham_3 | strain: C57BL/6 gender: male age: 8 weeks treatment: naïve | 3421.0 |
| GSM3562191 | DRG_WT_PSP_1 | strain: C57BL/6 gender: male age: 8 weeks treatment: 24h post surgery | 2765.0 |
| GSM3562192 | DRG_WT_PSP_2 | strain: C57BL/6 gender: male age: 8 weeks treatment: 24h post surgery | 2460.0 |
| GSM3562193 | DRG_WT_PSP_3 | strain: C57BL/6 gender: male age: 8 weeks treatment: 24h post surgery | 2444.0 |
| ID | GSE126662 |
| Title | Comparison between opioid (morphine) and vehicle treatments in mouse trigeminal ganglia and nucleus accumbens |
| Organism | Mus musculus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM3610703 | TG_M1: OIH_M1_Trigeminal_Ganglia | tissue: Trigeminal ganglia strain: C57BL/6J treatment: OIH age: 9-12 weeks old Sex: male | 463.49605285714284 |
| GSM3610704 | TG_M2: OIH_M2_Trigeminal_Ganglia | tissue: Trigeminal ganglia strain: C57BL/6J treatment: OIH age: 9-12 weeks old Sex: male | 656.8485650972272 |
| GSM3610705 | TG_M3: OIH_M3_Trigeminal_Ganglia | tissue: Trigeminal ganglia strain: C57BL/6J treatment: OIH age: 9-12 weeks old Sex: male | 687.2238600000001 |
| GSM3610706 | TG_M4: OIH_M4_Trigeminal_Ganglia | tissue: Trigeminal ganglia strain: C57BL/6J treatment: OIH age: 9-12 weeks old Sex: male | 482.02731942857145 |
| GSM3610707 | TG_M5: OIH_M5_Trigeminal_Ganglia | tissue: Trigeminal ganglia strain: C57BL/6J treatment: OIH age: 9-12 weeks old Sex: male | 555.4484285714286 |
| GSM3610708 | TG_V1: VehicleOIH_V1_Trigeminal_Ganglia | tissue: Trigeminal ganglia strain: C57BL/6J treatment: Vehicle age: 9-12 weeks old Sex: male | 778.3838108571429 |
| GSM3610709 | TG_V2: VehicleOIH_V2_Trigeminal_Ganglia | tissue: Trigeminal ganglia strain: C57BL/6J treatment: Vehicle age: 9-12 weeks old Sex: male | 1088.6225157142858 |
| GSM3610710 | TG_V3: VehicleOIH_V3_Trigeminal_Ganglia | tissue: Trigeminal ganglia strain: C57BL/6J treatment: Vehicle age: 9-12 weeks old Sex: male | 390.15172245284685 |
| GSM3610711 | TG_V4: VehicleOIH_V4_Trigeminal_Ganglia | tissue: Trigeminal ganglia strain: C57BL/6J treatment: Vehicle age: 9-12 weeks old Sex: male | 261.77560248 |
| GSM3610712 | TG_V5: VehicleOIH_V5_Trigeminal_Ganglia | tissue: Trigeminal ganglia strain: C57BL/6J treatment: Vehicle age: 9-12 weeks old Sex: male | 465.0762531428572 |
| GSM3610713 | NAc_M1: OIH_M1_Nucleus_Accumbens | tissue: Nucleus accumbens strain: C57BL/6J treatment: OIH age: 9-12 weeks old Sex: male | 230.33790000000002 |
| GSM3610714 | NAc_M2: OIH_M2_Nucleus_Accumbens | tissue: Nucleus accumbens strain: C57BL/6J treatment: OIH age: 9-12 weeks old Sex: male | 292.43478571428574 |
| GSM3610715 | NAc_M3: OIH_M3_Nucleus_Accumbens | tissue: Nucleus accumbens strain: C57BL/6J treatment: OIH age: 9-12 weeks old Sex: male | 311.52439414285715 |
| GSM3610716 | NAc_M4: OIH_M4_Nucleus_Accumbens | tissue: Nucleus accumbens strain: C57BL/6J treatment: OIH age: 9-12 weeks old Sex: male | 302.87341071428574 |
| GSM3610717 | NAc_M5: OIH_M5_Nucleus_Accumbens | tissue: Nucleus accumbens strain: C57BL/6J treatment: OIH age: 9-12 weeks old Sex: male | 269.111116 |
| GSM3610718 | NAc_V1: VehicleOIH_V1_Nucleus_Accumbens | tissue: Nucleus accumbens strain: C57BL/6J treatment: Vehicle age: 9-12 weeks old Sex: male | 214.9631 |
| GSM3610719 | NAc_V2: VehicleOIH_V2_Nucleus_Accumbens | tissue: Nucleus accumbens strain: C57BL/6J treatment: Vehicle age: 9-12 weeks old Sex: male | 363.40094142857146 |
| GSM3610720 | NAc_V3: VehicleOIH_V3_Nucleus_Accumbens | tissue: Nucleus accumbens strain: C57BL/6J treatment: Vehicle age: 9-12 weeks old Sex: male | 156.2574459895714 |
| GSM3610721 | NAc_V4: VehicleOIH_V4_Nucleus_Accumbens | tissue: Nucleus accumbens strain: C57BL/6J treatment: Vehicle age: 9-12 weeks old Sex: male | 236.82987685714286 |
| GSM3610722 | NAc_V5: VehicleOIH_V5_Nucleus_Accumbens | tissue: Nucleus accumbens strain: C57BL/6J treatment: Vehicle age: 9-12 weeks old Sex: male | 228.52246428571428 |
| ID | GSE163828 |
| Title | Regulation of electro-acupuncture(EA) and astragalus membranaceus (AM) on genes in bone marrow |
| Organism | Mus musculus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4988039 | BH190126-1_control | tissue: bone marrow | 6.67 |
| GSM4988040 | BH190126-1_treatment of astragalus membranaceus | tissue: bone marrow | 7.03 |
| GSM4988041 | BH190126-1_cisplatin | tissue: bone marrow | 6.93 |
| GSM4988042 | BH190126-1_treatment of electro-acupuncture | tissue: bone marrow | 7.03 |
| ID | GSE20160 |
| Title | Gene Expression Data from Prefrontal Cortex and Nucleus Accumbens from Inbred Strains of Mice |
| Organism | Mus musculus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM505749 | 129S1/SvImJ_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: 129S1/SvImJ | 55.863 |
| GSM505750 | A/J_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: A/J | 51.069 |
| GSM505751 | AKR/J_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: AKR/J | 50.1125 |
| GSM505752 | BALB/cByJ_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: BALB/cByJ | 60.858999999999995 |
| GSM505753 | BTBR_T+_tf/J_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: BTBR_T+_tf/J | 52.3385 |
| GSM505754 | BUB/BnJ_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: BUB/BnJ | 49.804 |
| GSM505755 | C3H/HeJ_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: C3H/HeJ | 51.7225 |
| GSM505756 | C57BL/6J_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: C57BL/6J | 43.869499999999995 |
| GSM505757 | C57BR/cdJ_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: C57BR/cdJ | 46.902 |
| GSM505758 | C58/J_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: C58/J | 47.682500000000005 |
| GSM505759 | CBA/J_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: CBA/J | 47.9985 |
| GSM505760 | CE/J_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: CE/J | 51.412 |
| GSM505761 | DBA/2J_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: DBA/2J | 30.7945 |
| GSM505762 | FVB/NJ_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: FVB/NJ | 38.0375 |
| GSM505763 | I/LnJ_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: I/LnJ | 46.9245 |
| GSM505764 | KK/HlJ_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: KK/HlJ | 45.9615 |
| GSM505765 | MA/MyJ_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: MA/MyJ | 40.399 |
| GSM505766 | MRL_MpJ_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: MRL/MpJ | 51.267500000000005 |
| GSM505767 | NOD/LtJ_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: NOD/LtJ | 40.5565 |
| GSM505768 | NON/LtJ_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: NON/LtJ | 46.709 |
| GSM505769 | NZO/HILtJ_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: NZO/HILtJ | 43.830000000000005 |
| GSM505770 | NZW_LacJ_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: NZW_LacJ | 46.1175 |
| GSM505771 | P/J_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: P/J | 47.857000000000006 |
| GSM505772 | PL/J_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: PL/J | 48.665000000000006 |
| GSM505773 | RIIIS/J_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: RIIIS/J | 41.111000000000004 |
| GSM505774 | SJL/J_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: SJL/J | 45.958999999999996 |
| GSM505775 | SM/J_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: SM/J | 63.964999999999996 |
| GSM505776 | SWR/J_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: SWR/J | 41.111 |
| GSM505777 | WSB/EiJ_Male_Frontal_Cortex | gender: male tissue: Frontal Cortex strain: WSB/EiJ | 47.3575 |
| GSM505778 | 129S1/SvImJ_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: 129S1/SvImJ | 45.702 |
| GSM505779 | A/J_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: A/J | 43.148999999999994 |
| GSM505780 | AKR/J_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: AKR/J | 50.466 |
| GSM505781 | BALB/cByJ_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: BALB/cByJ | 63.7345 |
| GSM505782 | BTBR_T+_tf/J_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: BTBR_T+_tf/J | 39.600500000000004 |
| GSM505783 | BUB/BnJ_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: BUB/BnJ | 45.551 |
| GSM505784 | C3H/HeJ_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: C3H/HeJ | 36.980999999999995 |
| GSM505785 | C57BL/6J_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: C57BL/6J | 35.064 |
| GSM505786 | C57BR/cdJ_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: C57BR/cdJ | 34.991 |
| GSM505787 | C58/J_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: C58/J | 36.409 |
| GSM505788 | CBA/J_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: CBA/J | 44.778 |
| GSM505789 | CE/J_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: CE/J | 51.233000000000004 |
| GSM505790 | DBA/2J_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: DBA/2J | 36.8885 |
| GSM505791 | FVB/NJ_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: FVB/NJ | 45.218 |
| GSM505792 | I/LnJ_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: I/LnJ | 39.836999999999996 |
| GSM505793 | KK/HlJ_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: KK/HlJ | 38.6775 |
| GSM505794 | MA/MyJ_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: MA/MyJ | 40.6635 |
| GSM505795 | NOD/LtJ_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: NOD/LtJ | 55.259 |
| GSM505796 | NON/LtJ_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: NON/LtJ | 53.589 |
| GSM505797 | NZW/LacJ_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: NZW/LacJ | 42.796 |
| GSM505798 | P/J_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: P/J | 44.168 |
| GSM505799 | PL/J_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: PL/J | 38.671 |
| GSM505800 | RIIIS/J_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: RIIIS/J | 39.3155 |
| GSM505801 | SJL/J_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: SJL/J | 40.552 |
| GSM505802 | SM/J_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: SM/J | 50.441500000000005 |
| GSM505803 | SWR/J_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: SWR/J | 47.1645 |
| GSM505804 | WSB/EiJ_Male_Nuc_Acc | gender: male tissue: Nucleus Accumbens strain: WSB/EiJ | 52.794000000000004 |
| ID | GSE205201 |
| Title | Hepatic responses of mice and rats to equivalent acetaminophen (APAP) insult [mouse] |
| Organism | Mus musculus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM6208462 | Mouse_Baseline_0h_1 | tissue: liver strain: C57Bl/6J Sex: male treatment: Untreated hours after treatment: 0 | 9.509727 |
| GSM6208463 | Mouse_Baseline_0h_2 | tissue: liver strain: C57Bl/6J Sex: male treatment: Untreated hours after treatment: 0 | 9.007806 |
| GSM6208464 | Mouse_Baseline_0h_3 | tissue: liver strain: C57Bl/6J Sex: male treatment: Untreated hours after treatment: 0 | 9.127931 |
| GSM6208465 | Mouse_Baseline_0h_4 | tissue: liver strain: C57Bl/6J Sex: male treatment: Untreated hours after treatment: 0 | 9.469945 |
| GSM6208466 | Mouse_Baseline_0h_5 | tissue: liver strain: C57Bl/6J Sex: male treatment: Untreated hours after treatment: 0 | 9.331872 |
| GSM6208467 | Mouse_Vehicle_03h_1 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 | 9.443385 |
| GSM6208468 | Mouse_Vehicle_03h_2 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 | 9.5302 |
| GSM6208469 | Mouse_Vehicle_03h_3 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 | 9.392151 |
| GSM6208470 | Mouse_Vehicle_03h_4 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 | 9.531005 |
| GSM6208471 | Mouse_Vehicle_03h_5 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 | 9.512835 |
| GSM6208472 | Mouse_Vehicle_06h_1 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 | 9.305585 |
| GSM6208473 | Mouse_Vehicle_06h_2 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 | 9.465492 |
| GSM6208474 | Mouse_Vehicle_06h_3 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 | 9.576733 |
| GSM6208475 | Mouse_Vehicle_06h_4 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 | 9.52924 |
| GSM6208476 | Mouse_Vehicle_06h_5 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 | 9.548467 |
| GSM6208477 | Mouse_Vehicle_09h_1 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 | 9.781064 |
| GSM6208478 | Mouse_Vehicle_09h_2 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 | 9.938643 |
| GSM6208479 | Mouse_Vehicle_09h_3 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 | 9.852173 |
| GSM6208480 | Mouse_Vehicle_09h_4 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 | 9.390155 |
| GSM6208481 | Mouse_Vehicle_09h_5 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 | 10.184785 |
| GSM6208482 | Mouse_Vehicle_24h_1 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 | 10.495417 |
| GSM6208483 | Mouse_Vehicle_24h_2 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 | 10.046478 |
| GSM6208484 | Mouse_Vehicle_24h_3 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 | 10.045112 |
| GSM6208485 | Mouse_Vehicle_24h_4 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 | 10.366405 |
| GSM6208486 | Mouse_Vehicle_24h_5 | tissue: liver strain: C57Bl/6J Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 | 10.374808 |
| GSM6208487 | Mouse_APAP_03h_1 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 3 | 9.064097 |
| GSM6208488 | Mouse_APAP_03h_2 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 3 | 9.084924 |
| GSM6208489 | Mouse_APAP_03h_3 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 3 | 9.15373 |
| GSM6208490 | Mouse_APAP_03h_4 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 3 | 9.475288 |
| GSM6208491 | Mouse_APAP_03h_5 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 3 | 8.973581 |
| GSM6208492 | Mouse_APAP_06h_1 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 6 | 9.111491 |
| GSM6208493 | Mouse_APAP_06h_2 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 6 | 9.280485 |
| GSM6208494 | Mouse_APAP_06h_3 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 6 | 9.207825 |
| GSM6208495 | Mouse_APAP_06h_4 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 6 | 9.344545 |
| GSM6208496 | Mouse_APAP_06h_5 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 6 | 9.387639 |
| GSM6208497 | Mouse_APAP_09h_1 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 9 | 8.837661 |
| GSM6208498 | Mouse_APAP_09h_2 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 9 | 9.315285 |
| GSM6208499 | Mouse_APAP_09h_3 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 9 | 9.34725 |
| GSM6208500 | Mouse_APAP_09h_4 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 9 | 9.313181 |
| GSM6208501 | Mouse_APAP_09h_5 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 9 | 9.274824 |
| GSM6208502 | Mouse_APAP_24h_1 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 24 | 9.015013 |
| GSM6208503 | Mouse_APAP_24h_2 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 24 | 9.914159 |
| GSM6208504 | Mouse_APAP_24h_3 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 24 | 9.774227 |
| GSM6208505 | Mouse_APAP_24h_4 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 24 | 9.56401 |
| GSM6208506 | Mouse_APAP_24h_5 | tissue: liver strain: C57Bl/6J Sex: male treatment: 300 mg/kg acetamnophen (o.g.) hours after treatment: 24 | 9.664996 |
| ID | GSE223541 |
| Title | Oxycodone withdrawal induces HDAC1/2-dependent transcriptional maladaptations in the reward pathway in a murine model of peripheral nerve injury |
| Organism | Mus musculus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM6958536 | B1 | tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: Sham condition: Sa | 1073.0 |
| GSM6958537 | C1 | tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: Sham condition: oxy | 1663.0 |
| GSM6958538 | F1 | tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: SNI condition: Sal | 402.0 |
| GSM6958539 | H1 | tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: SNI condition: oxy | 1832.0 |
| GSM6958540 | B2 | tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: Sham condition: Sal | 1777.0 |
| GSM6958541 | C2 | tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: Sham condition: oxy | 1351.0 |
| GSM6958542 | F2 | tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: SNI condition: Sal | 2096.0 |
| GSM6958543 | H2 | tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: SNI condition: oxy | 1016.0 |
| GSM6958544 | B3 | tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: Sham condition: Sal | 1877.0 |
| GSM6958545 | C3 | tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: Sham condition: oxy | 2051.0 |
| GSM6958546 | F3 | tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: SNI condition: Sal | 185.0 |
| GSM6958547 | H3 | tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: SNI condition: oxy | 2089.0 |
| GSM6958548 | B4 | tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: Sham condition: Sal | 1582.0 |
| GSM6958549 | C4 | tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: Sham condition: oxy | 811.0 |
| GSM6958550 | F4 | tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: SNI condition: Sal | 1225.0 |
| GSM6958551 | H4 | tissue: Brain strain: C57BL/6 Sex: male cell type: Nac genotype: SNI condition: oxy | 1754.0 |
| ID | GSE24829 |
| Title | Gene expression data from striatal regions of MPTP-intoxicated mouse brain by acupuncture |
| Organism | Mus musculus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM611081 | Control mouse 1 striatal regions | gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: Control | 8.341455 |
| GSM611082 | Control mouse 2 striatal regions | gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: Control | 8.431205 |
| GSM611083 | MPTP-treated mouse 1 striatal regions | gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: MPTP-treated | 8.72327 |
| GSM611084 | MPTP-treated mouse 2 striatal regions | gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: MPTP-treated | 8.39704 |
| GSM611085 | MPTP and acupoints acupuncture-treated mouse 1 striatal regions | gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: MPTP and acupoints acupuncture-treated | 8.466095 |
| GSM611086 | MPTP and acupoints acupuncture-treated mouse 2 striatal regions | gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: MPTP and acupoints acupuncture-treated | 8.37511 |
| GSM611087 | MPTP and nonacupoints acupuncture-treated mouse 1 striatal regions | gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: MPTP and nonacupoints acupuncture-treated | 8.561119999999999 |
| GSM611088 | MPTP and nonacupoints acupuncture-treated mouse 2 striatal regions | gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: MPTP and nonacupoints acupuncture-treated | 8.7915 |
| ID | GSE24830 |
| Title | Gene expression data from cervical spinal cord regions of MPTP-intoxicated mouse by acupuncture |
| Organism | Mus musculus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM611089 | Control mouse 1 cervical spinal cord regions | gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: Control | 8.64581 |
| GSM611090 | Control mouse 2 cervical spinal cord regions | gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: Control | 8.769075 |
| GSM611091 | MPTP-treated mouse 1 cervical spinal cord regions | gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: MPTP-treated | 8.92466 |
| GSM611092 | MPTP-treated mouse 2 cervical spinal cord regions | gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: MPTP-treated | 8.82369 |
| GSM611093 | MPTP and acupoints acupuncture-treated mouse 1 cervical spinal cord regions | gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: MPTP and acupoints acupuncture-treated | 8.89953 |
| GSM611094 | MPTP and acupoints acupuncture-treated mouse 2 cervical spinal cord regions | gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: MPTP and acupoints acupuncture-treated | 8.794715 |
| GSM611095 | MPTP and nonacupoints acupuncture-treated mouse 1 cervical spinal cord regions | gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: MPTP and nonacupoints acupuncture-treated | 9.048760000000001 |
| GSM611096 | MPTP and nonacupoints acupuncture-treated mouse 2 cervical spinal cord regions | gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: MPTP and nonacupoints acupuncture-treated | 9.37348 |
| ID | GSE24838 |
| Title | Gene expression data from brain striatal and spinal cord regions of MPTP-intoxicated mouse following acupuncture |
| Organism | Mus musculus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM611081 | Control mouse 1 striatal regions | gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: Control | 8.341455 |
| GSM611082 | Control mouse 2 striatal regions | gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: Control | 8.431205 |
| GSM611083 | MPTP-treated mouse 1 striatal regions | gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: MPTP-treated | 8.72327 |
| GSM611084 | MPTP-treated mouse 2 striatal regions | gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: MPTP-treated | 8.39704 |
| GSM611085 | MPTP and acupoints acupuncture-treated mouse 1 striatal regions | gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: MPTP and acupoints acupuncture-treated | 8.466095 |
| GSM611086 | MPTP and acupoints acupuncture-treated mouse 2 striatal regions | gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: MPTP and acupoints acupuncture-treated | 8.37511 |
| GSM611087 | MPTP and nonacupoints acupuncture-treated mouse 1 striatal regions | gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: MPTP and nonacupoints acupuncture-treated | 8.561119999999999 |
| GSM611088 | MPTP and nonacupoints acupuncture-treated mouse 2 striatal regions | gender: Male strain: C57BL/6 tissue: Striatal tissues developmental stage: Adult treatment: MPTP and nonacupoints acupuncture-treated | 8.7915 |
| GSM611089 | Control mouse 1 cervical spinal cord regions | gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: Control | 8.64581 |
| GSM611090 | Control mouse 2 cervical spinal cord regions | gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: Control | 8.769075 |
| GSM611091 | MPTP-treated mouse 1 cervical spinal cord regions | gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: MPTP-treated | 8.92466 |
| GSM611092 | MPTP-treated mouse 2 cervical spinal cord regions | gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: MPTP-treated | 8.82369 |
| GSM611093 | MPTP and acupoints acupuncture-treated mouse 1 cervical spinal cord regions | gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: MPTP and acupoints acupuncture-treated | 8.89953 |
| GSM611094 | MPTP and acupoints acupuncture-treated mouse 2 cervical spinal cord regions | gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: MPTP and acupoints acupuncture-treated | 8.794715 |
| GSM611095 | MPTP and nonacupoints acupuncture-treated mouse 1 cervical spinal cord regions | gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: MPTP and nonacupoints acupuncture-treated | 9.048760000000001 |
| GSM611096 | MPTP and nonacupoints acupuncture-treated mouse 2 cervical spinal cord regions | gender: Male strain: C57BL/6 tissue: Cervical spinal cord tissues developmental stage: Adult treatment: MPTP and nonacupoints acupuncture-treated | 9.37348 |
| ID | GSE26364 |
| Title | Gene expression changes in alpha GABA receptors in the mice brains after prolonged ketamine administration |
| Organism | Mus musculus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM647254 | Saline PFC 1 | strain: ICR tissue: prefrontal cortex Sex: female | 7.2969100000000005 |
| GSM647255 | Saline PFC 2 | strain: ICR tissue: prefrontal cortex Sex: female | 7.17199 |
| GSM647256 | Ketamine PFC 1 | strain: ICR tissue: prefrontal cortex Sex: female | 7.2137150000000005 |
| GSM647257 | Ketamine PFC 2 | strain: ICR tissue: prefrontal cortex Sex: female | 7.330405 |
| ID | GSE31827 |
| Title | Gene expression profiling in murine mesenchymal stem cells treated with local anesthetics (ropivacaine) |
| Organism | Mus musculus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM789386 | MSC_control1 | tissue: bone marrow strain: C57B6/J agent: no treatment sample collection time: 24 hrs | 7.913 |
| GSM789387 | MSC_control2 | tissue: bone marrow strain: C57B6/J agent: no treatment sample collection time: 24 hrs | 7.804 |
| GSM789388 | MSC_control3 | tissue: bone marrow strain: C57B6/J agent: no treatment sample collection time: 24 hrs | 7.879 |
| GSM789389 | MSC_control4 | tissue: bone marrow strain: C57B6/J agent: no treatment sample collection time: 24 hrs | 8.121 |
| GSM789390 | MSC_ROPI1 | tissue: bone marrow strain: C57B6/J agent: ropivacaine 100 uM sample collection time: 24 hrs | 7.94 |
| GSM789391 | MSC_ROPI2 | tissue: bone marrow strain: C57B6/J agent: ropivacaine 100 uM sample collection time: 24 hrs | 7.845 |
| GSM789392 | MSC_ROPI3 | tissue: bone marrow strain: C57B6/J agent: ropivacaine 100 uM sample collection time: 24 hrs | 7.918 |
| GSM789393 | MSC_ROPI4 | tissue: bone marrow strain: C57B6/J agent: ropivacaine 100 uM sample collection time: 24 hrs | 8.196 |
| ID | GSE35138 |
| Title | Gene expression data from thalamic regions of MPTP-intoxicated mouse brain by acupuncture |
| Organism | Mus musculus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM862520 | Control mouse 1 thalamic regions | gender: Male strain: C57BL/6 tissue: thalamic tissues developmental stage: Adult | 7.96641 |
| GSM862521 | Control mouse 2 thalamic regions | gender: Male strain: C57BL/6 tissue: thalamic tissues developmental stage: Adult | 7.965135 |
| GSM862522 | MPTP-treated mouse 1 thalamic regions | gender: Male strain: C57BL/6 tissue: thalamic tissues developmental stage: Adult | 8.4619 |
| GSM862523 | MPTP-treated mouse 2 thalamic regions | gender: Male strain: C57BL/6 tissue: thalamic tissues developmental stage: Adult | 8.002935 |
| GSM862524 | MPTP and acupoints acupuncture-treated mouse 1 thalamic regions | gender: Male strain: C57BL/6 tissue: thalamic tissues developmental stage: Adult | 8.17203 |
| GSM862525 | MPTP and acupoints acupuncture-treated mouse 2 thalamic regions | gender: Male strain: C57BL/6 tissue: thalamic tissues developmental stage: Adult | 8.22674 |
| GSM862526 | MPTP and nonacupoints acupuncture-treated mouse 1 thalamic regions | gender: Male strain: C57BL/6 tissue: thalamic tissues developmental stage: Adult | 8.494209999999999 |
| GSM862527 | MPTP and nonacupoints acupuncture-treated mouse 2 thalamic regions | gender: Male strain: C57BL/6 tissue: thalamic tissues developmental stage: Adult | 8.150425 |
| ID | GSE48293 |
| Title | Gene expression data from substantia nigral regions of MPTP-intoxicated mouse brain by acupuncture |
| Organism | Mus musculus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1174263 | Control mouse 1 substantia nigral regions | gender: Male strain: C57BL/6 tissue: substantia nigral tissues developmental stage: Adult treatment: Control | 7.50154 |
| GSM1174264 | Control mouse 2 substantia nigral regions | gender: Male strain: C57BL/6 tissue: substantia nigral tissues developmental stage: Adult treatment: Control | 8.35601 |
| GSM1174265 | MPTP-treated mouse 1 substantia nigral regions | gender: Male strain: C57BL/6 tissue: substantia nigral tissues developmental stage: Adult treatment: MPTP-treated | 8.647615 |
| GSM1174266 | MPTP-treated mouse 2 substantia nigral regions | gender: Male strain: C57BL/6 tissue: substantia nigral tissues developmental stage: Adult treatment: MPTP-treated | 8.65977 |
| GSM1174267 | MPTP and acupoints acupuncture-treated mouse 1 substantia nigral regions | gender: Male strain: C57BL/6 tissue: substantia nigral tissues developmental stage: Adult treatment: MPTP and acupoints acupuncture-treated | 8.49624 |
| GSM1174268 | MPTP and acupoints acupuncture-treated mouse 2 substantia nigral regions | gender: Male strain: C57BL/6 tissue: substantia nigral tissues developmental stage: Adult treatment: MPTP and acupoints acupuncture-treated | 8.777285 |
| GSM1174269 | MPTP and nonacupoints acupuncture-treated mouse 1 substantia nigral regions | gender: Male strain: C57BL/6 tissue: substantia nigral tissues developmental stage: Adult treatment: MPTP and nonacupoints acupuncture-treated | 8.488769999999999 |
| GSM1174270 | MPTP and nonacupoints acupuncture-treated mouse 2 substantia nigral regions | gender: Male strain: C57BL/6 tissue: substantia nigral tissues developmental stage: Adult treatment: MPTP and nonacupoints acupuncture-treated | 8.163595 |
| ID | GSE57771 |
| Title | Electroacupuncture Improves Trinitrobenzene Sulphonic Acid-Induced Colitis, Evaluated by Transcriptomic Study |
| Organism | Mus musculus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1388351 | Mock_Spleen_1 | strain: FVB tissue: Spleen | 108.7222 |
| GSM1388352 | Mock_Spleen_2 | strain: FVB tissue: Spleen | 106.6667 |
| GSM1388353 | TNBS_Spleen_1 | strain: FVB tissue: Spleen | 106.0556 |
| GSM1388354 | TNBS_Spleen_2 | strain: FVB tissue: Spleen | 103.5 |
| GSM1388355 | EA_Spleen_1 | strain: FVB tissue: Spleen | 118.2222 |
| GSM1388356 | EA_Spleen_2 | strain: FVB tissue: Spleen | 101.7778 |
| GSM1388357 | Mock_Colon_1 | strain: FVB tissue: Colon | 295.0 |
| GSM1388358 | Mock_Colon_2 | strain: FVB tissue: Colon | 144.5833 |
| GSM1388359 | TNBS_Colon_1 | strain: FVB tissue: Colon | 420.5833 |
| GSM1388360 | TNBS_Colon_2 | strain: FVB tissue: Colon | 134.8333 |
| GSM1388361 | EA_Colon_1 | strain: FVB tissue: Colon | 59.44444 |
| GSM1388362 | EA_Colon_2 | strain: FVB tissue: Colon | 139.3333 |
| ID | GSE6479 |
| Title | Analgesia of naloxone and morphine in wild-type and NY1DD sickle cell mice using BMAP cDNA microarrays |
| Organism | Mus musculus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM141569 | NY1DD Sickle Cell Mouse brains, NLX treated, 10mins. SCNLX-I 817 | Strain:NY1DD Sickle Cell Mice Gender: Male Age: 9 wks Drug: Naloxone for 10 mins.;Strain:NY1DD Sickle Cell Mice Gender: Male Age: 9 wks Drug: Saline for 10 mins. | 0.026415277 |
| GSM142384 | NY1DD Sickle Cell Mouse brains, NLX treated, 10mins. 819 SCNLX2 | Strain:NY1DD Sickle Cell Mice Gender: Male Age: 9 wks Drug: Naloxone for 10 mins.;Strain:NY1DD Sickle Cell Mice Gender: Male Age: 9 wks Drug: Saline for 10 mins. | -0.1624248 |
| GSM142385 | NY1DD Sickle Cell Mouse brains, NLX treated, 10mins. 825 SCNLX3 | Strain:NY1DD Sickle Cell Mice Gender: Male Age: 9 wks Drug: Naloxone for 10 mins.;Strain:NY1DD Sickle Cell Mice Gender: Male Age: 9 wks Drug: Saline for 10 mins. | 0.18020926 |
| GSM142386 | NY1DD Sickle Cell Mouse brains, MOR treated, 10mins. 819 SCMOR1 | Strain:NY1DD Sickle Cell Mice Gender: Male Age: 9 wks Drug: Morphine for 10 mins.; Strain:NY1DD Sickle Cell Mice Gender: Male Age: 9 wks Drug: Saline for 10 mins. | 0.3574423 |
| GSM142387 | NY1DD Sickle Cell Mouse brains, MOR treated, 10mins. 823 SCMOR2 | Strain:NY1DD Sickle Cell Mice Gender: Male Age: 9 wks Drug: Morphine for 10 mins.;Strain:NY1DD Sickle Cell Mice Gender: Male Age: 9 wks Drug: Saline for 10 mins. | 0.026065867 |
| GSM142388 | NY1DD Sickle Cell Mouse brains, MOR treated, 10mins. 825 SCMOR3 | Strain:NY1DD Sickle Cell Mice Gender: Male Age: 9 wks Drug: Morphine for 10 mins.;Strain:NY1DD Sickle Cell Mice Gender: Male Age: 9 wks Drug: Saline for 10 mins. | 0.19651753 |
| GSM148906 | C57BL/6J wild-type mouse brains, MOR treated, 10mins. 916 WTMOR 1 | Strain:C57BL/6J Mice Gender: Male Age: 9 wks Drug: Morphine for 10 mins.; Strain:C57BL/6J wild-type mice Gender: Male Age: 9 wks Drug: Saline for 10 mins. | -0.27105883 |
| GSM148908 | C57BL/6J wild-type mouse brains, MOR treated, 10mins. 916 WTMOR 2 | Strain:C57BL/6J Mice Gender: Male Age: 9 wks Drug: Morphine for 10 mins.; Strain:C57BL/6J wild-type mice Gender: Male Age: 9 wks Drug: Saline for 10 mins. | -0.82360536 |
| GSM148910 | C57BL/6J wild-type mouse brains, MOR treated, 10mins. 925 WTMOR3 | Strain:C57BL/6J Mice Gender: Male Age: 9 wks Drug: Morphine for 10 mins.; Strain:C57BL/6J wild-type mice Gender: Male Age: 9 wks Drug: Saline for 10 mins. | -0.09409276 |
| GSM149076 | C57BL/6J wild-type mouse brains, NLX treated, 10mins. 915 WTNLX 1 | Strain:C57BL/6J Mice Gender: Male Age: 9 wks Drug: Naloxone for 10 mins.;Strain:C57BL/6J wild-type mice Gender: Male Age: 9 wks Drug: Saline for 10 mins. | 0.24038264 |
| GSM149078 | C57BL/6J wild-type mouse brains, NLX treated, 10mins. 915 WTNLX 2 | Strain:C57BL/6J Mice Gender: Male Age: 9 wks Drug: Naloxone for 10 mins.;Strain:C57BL/6J wild-type mice Gender: Male Age: 9 wks Drug: Saline for 10 mins. | -0.16520563 |
| GSM149084 | C57BL/6J wild-type mouse brains, NLX treated, 10mins. 921 WTNLX 3 | Strain:C57BL/6J Mice Gender: Male Age: 9 wks Drug: Naloxone for 10 mins.;Strain:C57BL/6J wild-type mice Gender: Male Age: 9 wks Drug: Saline for 10 mins. | -0.20365115 |
| ID | GSE6578 |
| Title | Analgesia of naloxone in wild-type and NY1DD transgenic mouse model of sickle cell anemia using BMAP cDNA microarrays |
| Organism | Mus musculus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM141569 | NY1DD Sickle Cell Mouse brains, NLX treated, 10mins. SCNLX-I 817 | Strain:NY1DD Sickle Cell Mice Gender: Male Age: 9 wks Drug: Naloxone for 10 mins.; Strain:NY1DD Sickle Cell Mice Gender: Male Age: 9 wks Drug: Saline for 10 mins. | 0.026415277 |
| GSM142384 | NY1DD Sickle Cell Mouse brains, NLX treated, 10mins. 819 SCNLX2 | Strain:NY1DD Sickle Cell Mice Gender: Male Age: 9 wks Drug: Naloxone for 10 mins.;Strain:NY1DD Sickle Cell Mice Gender: Male Age: 9 wks Drug: Saline for 10 mins. | -0.1624248 |
| GSM142385 | NY1DD Sickle Cell Mouse brains, NLX treated, 10mins. 825 SCNLX3 | Strain:NY1DD Sickle Cell Mice Gender: Male Age: 9 wks Drug: Naloxone for 10 mins.;Strain:NY1DD Sickle Cell Mice Gender: Male Age: 9 wks Drug: Saline for 10 mins. | 0.18020926 |
| GSM149076 | C57BL/6J wild-type mouse brains, NLX treated, 10mins. 915 WTNLX 1 | Strain:C57BL/6J Mice Gender: Male Age: 9 wks Drug: Naloxone for 10 mins.;Strain:C57BL/6J wild-type mice Gender: Male Age: 9 wks Drug: Saline for 10 mins. | 0.24038264 |
| GSM149078 | C57BL/6J wild-type mouse brains, NLX treated, 10mins. 915 WTNLX 2 | Strain:C57BL/6J Mice Gender: Male Age: 9 wks Drug: Naloxone for 10 mins.; Strain:C57BL/6J wild-type mice Gender: Male Age: 9 wks Drug: Saline for 10 mins. | -0.16520563 |
| GSM149084 | C57BL/6J wild-type mouse brains, NLX treated, 10mins. 921 WTNLX 3 | Strain:C57BL/6J Mice Gender: Male Age: 9 wks Drug: Naloxone for 10 mins.; Strain:C57BL/6J wild-type mice Gender: Male Age: 9 wks Drug: Saline for 10 mins. | -0.20365115 |
